Key result
Dual-chamber leadless pacemaker demonstrates feasibility in a heart transplant patient requiring permanent pacing.
Case Report (n=1)
This case report describes the first use of a dual-chamber leadless pacemaker in a patient post-orthotopic heart transplant.
Answers are grounded in this paper and cite their sources.
Demonstrates feasibility of dual-chamber leadless pacing post-transplant; hypothesis-generating and requires prospective validation before clinical adoption.
Permanent pacemaker implantation is needed in approximately 5% of patients post orthotopic heart transplant (OHT).1-6 The primary indications for permanent pacing post-OHT include sinus node dysfunction occurring more often in the early postoperative phase (within 30 days following OHT) and atrioventricular block occurring more often in the later phase (>30 days post-OHT).1,3,5 Early postoperative sinus node dysfunction can be related to cardiac denervation or autonomic dysfunction, surgical injury to the sinus node, sinus node ischemia, or acute rejection.
No takes yet. Share an insight, caveat, or question.
Kaptein et al. (2023) conducted a case report in Orthotopic heart transplant (n=1). Dual-chamber leadless pacemaker was evaluated. A dual-chamber leadless pacemaker was utilized in a patient with an orthotopic heart transplant, a population where permanent pacing is needed in approximately 5% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: